ISI Web of Knowledge Take the next step  
Web of Science®
 
Previous Record (inactive) Record 1  of  1 Next Record (inactive)
Record from Web of Science®
PRECLINICAL EFFICACY OF A PROTOTYPE DNA VACCINE - ENHANCED PROTECTION AGAINST ANTIGENIC DRIFT IN INFLUENZA-VIRUS
Author(s): DONNELLY JJ, FRIEDMAN A, MARTINEZ D, MONTGOMERY DL, SHIVER JW, MOTZEL SL, ULMER JB, LIU MA
Source: NATURE MEDICINE    Volume: 1    Issue: 6    Pages: 583-587    Published: JUN 1995  
Times Cited: 216     References: 37     
Abstract: Vaccination with plasmid DNA expression vectors encoding foreign proteins elicits antibodies and cell-mediated immunity and protects against disease in animal models. We report a comparison of DNA vaccines, using contemporary human strains of virus, and clinically licensed (inactivated virus or subvirion) vaccines in preclinical animal models, to better predict their efficacy in humans. Influenza DNA vaccines elicited antibodies in both non-human primates and ferrets and protected ferrets against challenge with an antigenically distinct epidemic human influenza virus more effectively than the contemporary clinically licensed vaccine. These studies demonstrate that DNA vaccines may be more effective, particularly against different strains of virus, than inactivated virus or subvirion vaccines.
Document Type: Article
Language: English
Addresses:
1. MERCK SHARP & DOHME LTD, DEPT VIRUS & CELL BIOL, RES LABS, W POINT, PA 19486 USA
2. MERCK SHARP & DOHME LTD, DEPT LAB ANIM RESOURCES, RES LABS, W POINT, PA 19486 USA
Publisher: NATURE PUBLISHING CO, 345 PARK AVE SOUTH, NEW YORK, NY 10010-1707
Subject Category: Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental
IDS Number: RN101
ISSN: 1078-8956
Previous Record (inactive) Record 1  of  1 Next Record (inactive)
Record from Web of Science®
  
Thomson Reuters Logo